calendar
348 catalysts · 3,728 phase readout · 2,105 8k filing · 276 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
348 catalysts · 3,728 phase readout · 2,105 8k filing · 276 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: MWG. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: QZH. Advisory committee: TX. Decision: APPR
Supplement type: Real-Time Process. Product code: NIK. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: NAW. Advisory committee: RA. Decision: APPR
Supplement type: 30-Day Notice. Product code: MRA. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: QPY. Advisory committee: PM. Decision: OK30
Supplement type: Real-Time Process. Product code: LWP. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track. Product code: DSQ. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Special (Immediate Track). Product code: NPW. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: QFV. Advisory committee: CV. Decision: APPR
Supplement type: Special (Immediate Track). Product code: QQK. Advisory committee: GU. Decision: APPR
Supplement type: 30-Day Notice. Product code: NJL. Advisory committee: OR. Decision: OK30
Anticipated earnings call for ACME UNITED CORP ($ACU).
Therapy area: Dermatology. Indication: Chronic Urticaria
Anticipated earnings call for Sanofi ($SNY).
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Anticipated earnings call for NOVARTIS AG ($NVS).
Anticipated earnings call for INCYTE CORP ($INCY).
Anticipated earnings call for ECOLAB INC. ($ECL).
Anticipated earnings call for Orion Group Holdings Inc ($ORN).
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Anticipated earnings call for AbbVie Inc. ($ABBV).
Anticipated earnings call for ASTRAZENECA PLC ($AZN).
Anticipated earnings call for GSK plc ($GSK).
Anticipated earnings call for REGENERON PHARMACEUTICALS, INC. ($REGN).
Anticipated earnings call for TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA).
Anticipated earnings call for GLAUKOS Corp ($GKOS).
Anticipated earnings call for BIOGEN INC. ($BIIB).
Anticipated earnings call for Bausch & Lomb Corp ($BLCO).
Anticipated earnings call for SBA COMMUNICATIONS CORP ($SBAC).
Anticipated earnings call for AGIOS PHARMACEUTICALS, INC. ($AGIO).
Anticipated earnings call for IONIS PHARMACEUTICALS INC ($IONS).
Anticipated earnings call for Avantor, Inc. ($AVTR).
Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization
Therapy area: Genetic Disorders. Indication: Duchenne Muscular Dystrophy
Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion
Therapy area: Ophthalmology. Indication: Diabetic Retinopathy
Therapy area: Ophthalmology. Indication: Diabetic Macular Edema
Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease
Anticipated earnings call for MERIT MEDICAL SYSTEMS INC ($MMSI).
Anticipated earnings call for Merck & Co., Inc. ($MRK).
Anticipated earnings call for CARDINAL HEALTH INC ($CAH).
Anticipated earnings call for DEXCOM INC ($DXCM).